Cargando…

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial

OBJECTIVE: This was a flexible-dosed study to evaluate the efficacy and safety of duloxetine 30–120 mg once daily in the treatment of generalized anxiety disorder (GAD) in older adult patients. METHODS: Patients with GAD, who were at least 65 years of age, were randomly assigned to double-blind trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alaka, Karla J, Noble, William, Montejo, Angel, Dueñas, Héctor, Munshi, Autar, Strawn, Jeffrey R, Lenox-Smith, Alan, Ahl, Jonna, Bidzan, Leszek, Dorn, Brita, Ball, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285965/ https://www.ncbi.nlm.nih.gov/pubmed/24644106 http://dx.doi.org/10.1002/gps.4088

Ejemplares similares

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial
por: Arnold, Lesley M, et al.
Publicado: (2011)

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
por: Upadhyaya, Himanshu P., et al.
Publicado: (2019)

Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials
por: Micca, Joseph L, et al.
Publicado: (2013)

Efficacy of Duloxetine in Patients with Chronic Pain Conditions
por: Skljarevski, Vladimir, et al.
Publicado: (2011)

Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis
por: Li, Hu, et al.
Publicado: (2014)

Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo
por: Gao, Y, et al.
Publicado: (2015)

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports
por: Perahia, David G, et al.
Publicado: (2013)

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
por: Harada, E, et al.
Publicado: (2015)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
por: Chappell, Amy S, et al.
Publicado: (2009)

A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
por: Murakami, Masato, et al.
Publicado: (2015)

Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial
por: Lin, Alex Tong-Long, et al.
Publicado: (2008)

Efficacy of postoperative analgesia with duloxetine in posthemorrhoidectomy pain: a prospective, randomized, double-blind and placebo-controlled trial
por: Gerber, Marlus Tavares, et al.
Publicado: (2022)

Duloxetine in Reducing Catheter-Related Bladder Discomfort: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
por: Rath, Amrita, et al.
Publicado: (2023)

Duloxetine for the treatment of generalized anxiety disorder: a review
por: Khan, Ahsan Y, et al.
Publicado: (2009)

Analgesic effect of duloxetine compared to nortryptiline in patients with painful neuropathy: A randomized, double-blind, placebo-controlled trial
por: Mohammadali Bayani, Mohammadali, et al.
Publicado: (2021)

Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo‐controlled trial of duloxetine
por: Kwakye, Isaac N., et al.
Publicado: (2016)

Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
por: Konno, Shinichi, et al.
Publicado: (2016)

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
por: Uchio, Yuji, et al.
Publicado: (2018)

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017)

Effect of Preoperative Duloxetine on Opioid Consumption in Women Undergoing Abdominal Hysterectomy: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Bastanhagh, Ehsan, et al.
Publicado: (2020)

Analgesic effect of perioperative duloxetine in patients after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial
por: Yuan, Mingcheng, et al.
Publicado: (2022)

A randomized, double-blinded, placebo-controlled clinical trial of duloxetine hydrochloride enteric-coated tablets in the treatment of refractory chronic cough
por: Wang, Shengyuan, et al.
Publicado: (2023)

Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice
por: Patel, Sonam, et al.
Publicado: (2015)

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
por: Enomoto, Hiroyuki, et al.
Publicado: (2017)

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Duloxetine hydrochloride
por: Bhadbhade, Mohan, et al.
Publicado: (2009)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Withdrawal syndrome after donepezil cessation in a patient with dementia
por: Bidzan, Leszek, et al.
Publicado: (2012)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan, Leszek, et al.
Publicado: (2020)

Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia
por: Bidzan, Mariola, et al.
Publicado: (2017)

Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
por: Tokuoka, Hirofumi, et al.
Publicado: (2017)

Clinical meaningfulness of duloxetine’s effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial
por: Yue, Li, et al.
Publicado: (2019)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
por: Hong, Jihyung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mskepurlum3sfg9r0hu25ehfr5